168 related articles for article (PubMed ID: 21181610)
61. Colonic Squamous Cell Carcinoma in a Patient With Lynch Syndrome: Case Report and Highlights on the Role of Biomarker-Led Management.
Kussaibati R; Marks P; Chapman J; Miller B; Baijal S
Clin Colorectal Cancer; 2021 Dec; 20(4):e226-e232. PubMed ID: 34272151
[No Abstract] [Full Text] [Related]
62. Lynch syndrome-associated kidney cancer.
Ferrer Márquez M; Moreno Serrano A; Maturana Ibáñez V; Reina Duarte A
Rev Esp Enferm Dig; 2011 Jun; 103(6):339-40. PubMed ID: 21736408
[No Abstract] [Full Text] [Related]
63. Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer.
Cross DS; Rahm AK; Kauffman TL; Webster J; Le AQ; Spencer Feigelson H; Alexander G; Meier P; Onitilo AA; Pawloski PA; Williams AE; Honda S; Daida Y; McCarty CA; Goddard KA;
Genet Med; 2013 Dec; 15(12):933-40. PubMed ID: 23639899
[TBL] [Abstract][Full Text] [Related]
64. Lynch syndrome: five unanswered questions.
Castellsagué E; Foulkes WD
Clin Genet; 2015 Jun; 87(6):503-6. PubMed ID: 25737380
[No Abstract] [Full Text] [Related]
65. Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma.
Papke DJ; Nowak JA; Yurgelun MB; Frieden A; Srivastava A; Lindeman NI; Sholl LM; MacConaill LE; Dong F
Mod Pathol; 2018 Dec; 31(12):1882-1890. PubMed ID: 29955144
[TBL] [Abstract][Full Text] [Related]
66. Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD).
Seppälä TT; Dominguez-Valentin M; Sampson JR; Møller P
Fam Cancer; 2021 Jan; 20(1):35-39. PubMed ID: 32507935
[TBL] [Abstract][Full Text] [Related]
67. American Gastroenterological Association Institute and College of American Pathologists Quality Measure Development for Detection of Mismatch Repair Deficiency and Lynch Syndrome Management.
Leiman DA; Cardona DM; Kupfer SS; Rosenberg J; Bocsi GT; Hampel H;
Gastroenterology; 2022 Feb; 162(2):360-365. PubMed ID: 34666049
[No Abstract] [Full Text] [Related]
68. Constitutional mismatch repair-deficiency syndrome.
Wimmer K; Kratz CP
Haematologica; 2010 May; 95(5):699-701. PubMed ID: 20442441
[No Abstract] [Full Text] [Related]
69. Response.
Win AK; Jenkins MA
J Natl Cancer Inst; 2013 Dec; 105(23):1837-8. PubMed ID: 24168970
[No Abstract] [Full Text] [Related]
70. Unsolicited information letters to increase awareness of Lynch syndrome and familial colorectal cancer: reactions and attitudes.
Petersen HV; Frederiksen BL; Lautrup CK; Lindberg LJ; Ladelund S; Nilbert M
Fam Cancer; 2019 Jan; 18(1):43-51. PubMed ID: 29651783
[TBL] [Abstract][Full Text] [Related]
71. Impact of colonoscopic screening in Familial Colorectal Cancer Type X.
Hatfield E; Green JS; Woods MO; Warden G; Parfrey PS
Mol Genet Genomic Med; 2018 Nov; 6(6):1021-1030. PubMed ID: 30300963
[TBL] [Abstract][Full Text] [Related]
72. Lynch Syndrome-Associated Colorectal Cancer.
Sinicrope FA
N Engl J Med; 2018 Aug; 379(8):764-773. PubMed ID: 30134129
[No Abstract] [Full Text] [Related]
73. A comparative cost analysis of two screening strategies for colorectal cancer in Lynch Syndrome in a South African tertiary hospital.
Johnson Y; Goldberg P; Moodley J; Algar U; Thomson S; Sinanovic E; Ramesar R
Cancer Causes Control; 2023 Feb; 34(2):161-169. PubMed ID: 36355273
[TBL] [Abstract][Full Text] [Related]
74. Hereditary and familial colorectal cancer.
Ponz de Leon M
Recent Results Cancer Res; 1994; 136():203-37. PubMed ID: 7863096
[No Abstract] [Full Text] [Related]
75. Noncoding Aberrations in Mismatch Repair Genes Underlie a Substantial Part of the Missing Heritability in Lynch Syndrome.
Te Paske IBAW; Mensenkamp AR; Neveling K; ; Hoogerbrugge N; Ligtenberg MJL; De Voer RM
Gastroenterology; 2022 Dec; 163(6):1691-1694.e7. PubMed ID: 36037994
[No Abstract] [Full Text] [Related]
76. 8q23.3 and 11q23.1 as modifying loci influencing the risk for CRC in Lynch syndrome.
Talseth-Palmer BA; Scott RJ; Vasen HF; Wijnen JT
Eur J Hum Genet; 2012 May; 20(5):487-8; author reply 488. PubMed ID: 22166948
[No Abstract] [Full Text] [Related]
77. Cumulative incidence of metachronous colorectal cancer risk for mismatch repair gene mutation carriers is overestimated.
Renehan AG
Gut; 2012 May; 61(5):783; author reply 783-4. PubMed ID: 21873468
[No Abstract] [Full Text] [Related]
78. Screening for hereditary colorectal carcinoma.
Järvinen HJ; Mecklin JP
Scand J Gastroenterol; 1989 Dec; 24(10):1153-8. PubMed ID: 2557667
[No Abstract] [Full Text] [Related]
79. Screening for Lynch syndrome in the general population-letter.
Sadeghi S; Barzi A; Kattan MW; Meropol NJ
Cancer Prev Res (Phila); 2011 Mar; 4(3):471; author reply 472. PubMed ID: 21372042
[No Abstract] [Full Text] [Related]
80. Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain: a multicentre, prospective, nationwide study.
Piñol V; Andreu M; Castells A; Payá A; Bessa X; Rodrigo J;
Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):39-45. PubMed ID: 15095851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
